Cathay Biotech (688065)
Search documents
一号文件从“三向”部署农业创新,合成生物赛道火热
合成生物学与绿色生物制造· 2026-02-04 10:55
全球政策进展 | 一号文件 【SynBioCon】 第一时间获悉,2月4日上午,国务院新闻办公室举行新闻发布会,介绍锚定农业农村现代化、扎实推进乡村全面振兴有关情况,并答记 者问。 有记者提问, 今年的中央一号文件在推进农业科技创新、发展新质生产力方面有哪些关键的部署? 中央财办副主任、中央农办副主任 祝卫东 表示, 农业的出路在现代化,农业现代化的关键在科技进步和创新。今年中央一号文件围绕农业科技创新、 发展农业新质生产力, 主要从三个方面进行了部署: 以今年的中央一号文件来看,秸秆综合利用 从"支持"到"提升能力" 。这意味着国家希望看到更高附加值的利用方式。简单说, 不是"用掉就行",而 是"用掉后能赚钱" 。 | 年份 | 秸秆利用表述 | 农膜污染治理表述 | | --- | --- | --- | | 2020 | 推进秸秆综合利用 | 加强农膜污染治理 | | 2021 | 全面实施秸秆综合利用行 | 全面实施农膜回收行动, | | | 动 | 加强可降解农膜研发推广 | | 2022 | 支持秸秆综合利用 | 推进农膜科学使用回收 | | | 加快推进秸秆养畜;建立 | 建立健全农膜等农业废弃 ...
凯赛生物今日大宗交易折价成交19.7万股,成交额916.44万元
Xin Lang Cai Jing· 2026-02-02 09:41
2月2日,凯赛生物大宗交易成交19.7万股,成交额916.44万元,占当日总成交额的1.57%,成交价46.52 元,较市场收盘价53.63元折价13.26%。 | 以示范立日记 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券商稼 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( *) 买入营业部 | | | 卖出营业部 是否为专场 | | 026-02-02 | 凯赛生物 | 688065 | 46.52 916.44 | 19.7 | 公營運發點落落燈 | ី ка | ...
五部门出台零碳工厂建设意见,美国拟敲定年度生物燃料配额
Huaan Securities· 2026-01-25 13:33
Investment Rating - Industry Rating: Overweight [2] Core Insights - The chemical industry is experiencing a dual drive of cyclical recovery and growth, with a recommendation to focus on sectors such as organic silicon, PTA, polyester filament, caprolactam, spandex, vitamins, sweeteners, refrigerants, and phosphorus chemicals [5][6] - The organic silicon industry is entering a recovery phase, with new applications becoming key growth drivers. From 2019 to 2024, domestic DMC capacity is expected to expand rapidly, leading to a temporary oversupply and price decline. However, by 2025, no new capacity is anticipated, and demand from emerging sectors like new energy vehicles and photovoltaics is expected to maintain high growth [5][6] - The PTA/polyester filament industry is approaching a turning point, with capacity expansion cycles nearing their end. The demand side is expected to continue growing, supported by improved external demand due to easing trade tensions [6] - Refrigerants are entering a high prosperity cycle due to quota policies that will reduce supply while demand remains stable, driven by market expansion in Southeast Asia and the development of heat pumps and cold chain markets [7] - The synthetic biology sector is poised for significant growth as fossil-based materials face disruptive challenges, with a focus on energy-efficient products and the potential for bio-based materials to see explosive demand [8] - OLED technology is rapidly penetrating various markets, with government policies supporting the development of new display industries and accelerating the localization of key materials and equipment [9] - The demand for electronic chemicals is increasing due to the rapid growth of the semiconductor industry, particularly in China, where the market is heavily reliant on imports [11] Summary by Sections Industry Performance - The chemical sector ranked 4th in overall performance for the week of January 19-23, 2026, with a gain of 7.29%, outperforming the Shanghai Composite Index by 6.45 percentage points [5][20] - The top-performing sub-sectors included textile chemical products (13.10%), nitrogen fertilizers (10.58%), and other chemical raw materials (10.09%) [21] Key Company Dynamics - The top three gaining companies for the week were Jianghua Micro (46.41%), Jiuding New Materials (28.47%), and Hongbaoli (26.73%) [26] - The companies in focus for potential investment include KaiSai Biological, Huaheng Biological, and other leading firms in synthetic biology and electronic chemicals [8][11][32] Industry Developments - The Ministry of Industry and Information Technology has issued guidelines for the construction of zero-carbon factories, aiming to establish a benchmark by 2027 across various sectors [35] - The U.S. government plans to finalize the 2026 biofuel blending quotas, maintaining high growth targets while addressing industry concerns [35]
凯赛生物:目前产品出口主要涉及欧洲、北美和亚太地区
Zheng Quan Ri Bao Wang· 2026-01-22 13:41
证券日报网讯1月22日,凯赛生物在互动平台回答投资者提问时表示,公司作为一家致力于生物制造产 业化、并积极开拓全球市场的企业,始终以开放的姿态与全球客户开展合作,目前产品出口主要涉及欧 洲、北美和亚太地区。 ...
凯赛生物:在生物基复合材料的联合开发与应用方面,公司正与招商局集团旗下相关单位紧密协作
Zheng Quan Ri Bao Wang· 2026-01-22 12:13
证券日报网讯1月22日,凯赛生物在互动平台回答投资者提问时表示,在生物基复合材料的联合开发与 应用方面,公司正与招商局集团旗下相关单位紧密协作,针对集装箱、建筑模板等多个潜在应用场景, 持续进行产品测试、工艺优化与性能验证工作。双方团队保持着高效、务实的沟通,共同解决产品开发 过程中的关键问题,部分产品已交付小批量订单。 ...
凯赛生物:将人工智能与生物技术深度融合,是公司构筑核心竞争力的关键战略方向
Zheng Quan Ri Bao Wang· 2026-01-22 12:13
证券日报网讯1月22日,凯赛生物在互动平台回答投资者提问时表示,将人工智能(AI)与生物技术(BT) 深度融合,是公司构筑核心竞争力的关键战略方向,公司通过内部平台建设与外部生态协同(包括与分 子之心等伙伴的合作),不断完善技术体系。公司期望以此构建面向未来的、具备差异化的技术护城 河,巩固并扩大公司在生物制造领域的领先优势。 ...
凯赛生物:在生物基复合材料领域的各项合作与市场拓展工作均在稳步推进中
Zheng Quan Ri Bao Wang· 2026-01-22 11:41
证券日报网讯1月22日,凯赛生物在互动平台回答投资者提问时表示,公司在生物基复合材料领域的各 项合作与市场拓展工作均在稳步推进中。针对建筑模板,公司与相关合作方保持积极沟通,共同致力于 解决产业化落地过程中的各类具体事项,力求为市场提供成熟、可靠、具备竞争力的解决方案。 ...
免费领取!《2025中国合成生物制造产业发展白皮书》
synbio新材料· 2026-01-20 08:47
Core Insights - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative sector, which is seen as a new growth point that can help optimize industrial structures and transform economic models [1]. Group 1: Current State and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current status and trends in biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study of the US and China in this field [5]. Group 2: Policy Landscape - The white paper discusses major policies affecting biomanufacturing both domestically and internationally for the years 2024-2025 [5]. Group 3: Industry Map and Applications - It provides a comprehensive map of the Chinese biomanufacturing industry and analyzes the industry chain along with key application directions, including biomanufacturing in pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises - The report identifies ten leading enterprises in the Chinese biomanufacturing sector, detailing their contributions and roles within the industry [5][6]. Group 5: Company Strategies - It outlines the synthetic biology strategies of 15 listed companies, summarizing their development approaches and corresponding popular products [5][6]. Group 6: Investment and Challenges - The white paper reviews the investment and financing situation in domestic synthetic biology from 2024 to mid-2025 and discusses the challenges faced by the biomanufacturing industry in China, along with proposed countermeasures [5][6].
167股连续5日或5日以上获融资净买入
Zheng Quan Shi Bao Wang· 2026-01-19 03:34
Core Viewpoint - As of January 16, a total of 167 stocks in the Shanghai and Shenzhen markets have experienced net financing inflows for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Notable Financing Inflows - The stock with the longest consecutive net financing inflow is Shenwan Hongyuan, which has seen net inflows for 14 consecutive trading days [1] - Other stocks with significant consecutive net financing inflows include China Merchants Bank, Jiayuan Technology, Lens Technology, Songsheng Co., Kaisa Bio, Gansu Expressway, New Asia Electronics, and Huaten Hotel [1]
新材料产业周报:三星显示正式启动第8.6代OLED面板量产,力鸿一号圆满完成亚轨道飞行试验-20260118
Guohai Securities· 2026-01-18 12:21
Investment Rating - The report maintains a "Recommended" rating for the new materials industry [1] Core Insights - The new materials sector is positioned as a crucial direction for the chemical industry, currently experiencing rapid growth in downstream demand. With policy support and technological breakthroughs, domestic new materials are expected to accelerate into a long-term growth phase. The report emphasizes that "one generation of materials leads to one generation of industry," highlighting the foundational nature of the new materials industry as the material basis for other sectors [3][4]. Summary by Sections 1. Electronic Information Sector - Focus areas include semiconductor materials, display materials, and 5G materials. Samsung Display has officially launched mass production of the 8.6 generation OLED panels, which will be used in new laptops this year [5][20]. 2. Aerospace Sector - Key materials of interest are PI films, precision ceramics, and carbon fibers. The successful suborbital flight test of the Lihong No. 1 vehicle demonstrates advancements in low-cost and flexible launch capabilities [7]. 3. New Energy Sector - Focus on photovoltaic materials, lithium-ion batteries, proton exchange membranes, and hydrogen storage materials. India is projected to become the second-largest solar market globally by 2026, driven by steady installation growth [9]. 4. Biotechnology Sector - Key areas include synthetic biology and scientific services. A team from Tsinghua University in Shenzhen has developed a 3D-printed "mini heart" that mimics the rhythmic beating of a real heart, with future applications in organ printing anticipated [11]. 5. Energy Conservation and Environmental Protection Sector - Focus on adsorbent resins, membrane materials, and biodegradable plastics. The Ministry of Industry and Information Technology has launched an action plan to promote high-quality development of industrial internet platforms, aiming for over 450 influential platforms by 2028 [13]. 6. Key Companies and Earnings Forecast - The report highlights several companies with their respective stock prices and earnings per share (EPS) forecasts for 2024A, 2025E, and 2026E, along with their price-to-earnings (PE) ratios and investment ratings. Notable companies include: - Ruihua Tai (688323.SH): EPS forecast of 0.26 for 2026E, rated as "Increase" [14] - Guangwei Composite (300699.SZ): EPS forecast of 0.97 for 2026E, rated as "Buy" [14] - Zhongfu Shenying (688295.SH): EPS forecast of 0.23 for 2026E, rated as "Buy" [14] - Wanrun Co., Ltd. (002643.SZ): EPS forecast of 0.53 for 2026E, rated as "Buy" [14] - Dinglong Co., Ltd. (300054.SZ): EPS forecast of 0.96 for 2026E, rated as "Buy" [14]